Inhaled nitric oxide (INO) is a potent vasodilator used as a bridge in treating severe respiratory failure and transporting patients to specialized centers. Although historically associated with risks, particularly renal impairment, it has demonstrated a transient improvement in oxygenation in patients with acute respiratory distress. This presentation argues for its increased utilization in retrieval medicine, emphasizing its potential benefits over ECMO in specific cases.